Kevin Cowart

Assistant Professor

University of South Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kevin Cowart is an Assistant Professor at the University of South Florida, USA. His research focuses on diabetes management, particularly the efficacy of glucose monitoring technologies and pharmacological treatments for type 2 diabetes. Recent contributions include investigations into the clinical outcomes of continuous glucose monitoring and collaborative practices in diabetes care.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Karen Kier

Professor of Pharmacy Practice, Director of Drug and Health Information

Ohio Northern University

UNITED STATES

View details

Melissa Somma McGivney

Associate Dean for Community Partnerships, Professor

University of Pittsburgh

UNITED STATES

View details

Raechel White

University of South Florida

UNITED STATES

View details

Kevin Olson

Assistant Professor, Director ITEHC Academy

University of South Florida

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kevin Cowart

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Impact of Pharmacist-Led Continuous Glucose Monitoring on Clinical Outcomes in People With Type 2 Diabetes in Primary Care: Protocol for a Prospective Cohort Study

Is there a role for continuous glucose monitoring beyond diabetes? Emerging applications in new populations

Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes

Collaboration between pharmacists in community pharmacy and ambulatory clinic settings: Current state and future directions

A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes

Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial

Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists

Pharmacist-Physician Collaborative Practice to Improve Diabetes Care at Tampa General Medical Group

Addressing Overbasalization to Achieve Glycemic Targets

Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real‐world, population‐based cohort study

Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes

Practicable Measurement and Identification of Overbasalization

Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial

Collaborators (4)

Karen Kier

Melissa Somma McGivney

Raechel White

Kevin Olson

Make your next move.